Cancer Research Cancer Epigenetics  Genetics and Biology of Brain Cancer
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Altuwaijri, S.
Right arrow Articles by Chang, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Altuwaijri, S.
Right arrow Articles by Chang, C.
[Cancer Research 63, 7106-7112, November 1, 2003]
© 2003 American Association for Cancer Research


Regular Articles

Interruption of Nuclear Factor {kappa}B Signaling by the Androgen Receptor Facilitates 12-O-Tetradecanoylphorbolacetate-Induced Apoptosis in Androgen-sensitive Prostate Cancer LNCaP Cells

Saleh Altuwaijri, Hui-Kuan Lin, Kuang-Hsiang Chuang, Wen-Jye Lin, Shuyuan Yeh, LeRoy A. Hanchett, Mujib M. Rahman, Hong-Yo Kang, Meng-Ying Tsai, Yanqing Zhang, Lin Yang and Chawnshang Chang1

George Whipple Laboratory for Cancer Research, Departments of Pathology, Urology, and Radiation Oncology, University of Rochester Medical Center, Rochester, New York 14642 [S. A., H-K. L., K-H. C., S. Y., W-J. L., L. A. H., M. M. R., L. Y., Y. Z., C. C.], and Graduate Institute of Clinical Medical Sciences and Center for Menopause and Reproductive Medicine Research, Chang Gung University, Taiwan 833, Republic of China [H-Y. K., M-Y. T.]

12-O-tetradecanoylphorbolacetate (TPA) influences proliferation, differentiation, and apoptosis in a variety of cells including prostate cancer cells. Here, we show that androgen treatment potentiates TPA-induced apoptosis in androgen-sensitive prostate cancer LNCaP cells but not in androgen-independent prostate cancer cell lines DU145 and PC-3. The use of the antiandrogen bicalutamide (Casodex) rescued LNCaP cells from 5-{alpha}-dihydrotestosterone (DHT)/TPA-induced apoptosis, suggesting that DHT/TPA-induced apoptosis is mediated by androgen/androgen receptor (AR). In addition, a caspase-3 inhibitor (Ac-DEVD-CHO) reduced the level of apoptosis, suggesting that DHT/TPA-mediated apoptosis occurs through a caspase-3-dependent pathway. A functional reporter assay using nuclear factor (NF) {kappa}B-luciferase and an electromobility gel shift assay showed that DHT suppressed NF{kappa}B activity. In addition, apoptosis mediated by combined DHT/TPA treatment was abrogated by overexpression of the NF{kappa}B subunit p65 in LNCaP-p65 cells, suggesting that NF{kappa}B may play an important role in regulating the effects of androgen/AR and TPA on apoptosis. Furthermore, use of the c-Jun N-terminal kinase (JNK) inhibitor SB202190 showed that the combination of DHT/TPA increased JNK activation in LNCaP cells but not in LNCaP-p65 cells, demonstrating that NF{kappa}B may be able to suppress JNK activity. These results indicate that androgen/AR facilitates TPA-induced apoptosis by interruption of the NF{kappa}B signaling pathway, leading to activation of JNK in LNCaP cells. These data describe a signaling pathway that could potentially be useful in proposed therapeutic treatment strategies exploiting combinations of different agents that control apoptosis in prostate tumors.




This article has been cited by other articles:


Home page
Am. J. Pathol.Home page
L. Zhang, S. Altuwaijri, F. Deng, L. Chen, P. Lal, U. K. Bhanot, R. Korets, S. Wenske, H. G. Lilja, C. Chang, et al.
NF-{kappa}B Regulates Androgen Receptor Expression and Prostate Cancer Growth
Am. J. Pathol., August 1, 2009; 175(2): 489 - 499.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
S. Altuwaijri, K.-H. Chuang, K.-P. Lai, J.-J. Lai, H.-Y. Lin, F. M. Young, A. Bottaro, M.-Y. Tsai, W.-P. Zeng, H.-C. Chang, et al.
Susceptibility to Autoimmunity and B Cell Resistance to Apoptosis in Mice Lacking Androgen Receptor in B Cells
Mol. Endocrinol., April 1, 2009; 23(4): 444 - 453.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
Y. J. Arnoldussen, P. I. Lorenzo, M. E. Pretorius, H. Waehre, B. Risberg, G. M. Maelandsmo, H. E. Danielsen, and F. Saatcioglu
The Mitogen-Activated Protein Kinase Phosphatase Vaccinia H1-Related Protein Inhibits Apoptosis in Prostate Cancer Cells and Is Overexpressed in Prostate Cancer
Cancer Res., November 15, 2008; 68(22): 9255 - 9264.
[Abstract] [Full Text] [PDF]


Home page
Endocr Relat CancerHome page
H. L. Goel, J. Li, S. Kogan, and L. R Languino
Integrins in prostate cancer progression
Endocr. Relat. Cancer, September 1, 2008; 15(3): 657 - 664.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
Y. Niu, S. Yeh, H. Miyamoto, G. Li, S. Altuwaijri, J. Yuan, R. Han, T. Ma, H.-C. Kuo, and C. Chang
Tissue Prostate-Specific Antigen Facilitates Refractory Prostate Tumor Progression via Enhancing ARA70-Regulated Androgen Receptor Transactivation
Cancer Res., September 1, 2008; 68(17): 7110 - 7119.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
X. Zhang, W. Li, and A. F. Olumi
Low-Dose 12-O-Tetradecanoylphorbol-13-Acetate Enhances Tumor Necrosis Factor Related Apoptosis-Inducing Ligand Induced Apoptosis in Prostate Cancer Cells
Clin. Cancer Res., December 1, 2007; 13(23): 7181 - 7190.
[Abstract] [Full Text] [PDF]


Home page
Mol Cancer ResHome page
B. Peant, J.-S. Diallo, L. Lessard, N. Delvoye, C. Le Page, F. Saad, and A.-M. Mes-Masson
Regulation of I{kappa}B Kinase {varepsilon} Expression by the Androgen Receptor and the Nuclear Factor-{kappa}B Transcription Factor in Prostate Cancer
Mol. Cancer Res., January 1, 2007; 5(1): 87 - 94.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
X. Zheng, R. L. Chang, X.-X. Cui, G. E. Avila, V. Hebbar, M. Garzotto, W. J. Shih, Y. Lin, S.-E. Lu, A. B. Rabson, et al.
Effects of 12-O-Tetradecanoylphorbol-13-acetate (TPA) in Combination with Paclitaxel (Taxol) on Prostate Cancer LNCaP Cells Cultured In vitro or Grown as Xenograft Tumors in Immunodeficient Mice.
Clin. Cancer Res., June 1, 2006; 12(11): 3444 - 3451.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. M. Gonzalez-Guerrico and M. G. Kazanietz
Phorbol Ester-induced Apoptosis in Prostate Cancer Cells via Autocrine Activation of the Extrinsic Apoptotic Cascade: A KEY ROLE FOR PROTEIN KINASE C{delta}
J. Biol. Chem., November 25, 2005; 280(47): 38982 - 38991.
[Abstract] [Full Text] [PDF]


Home page
Journals of Gerontology Series A: Biological Sciences and Medical SciencesHome page
E. K. Go, K. J. Jung, J. Y. Kim, B. P. Yu, and H. Y. Chung
Betaine Suppresses Proinflammatory Signaling During Aging: The Involvement of Nuclear Factor-{kappa}B via Nuclear Factor-Inducing Kinase/I{kappa}B Kinase and Mitogen-Activated Protein Kinases
J. Gerontol. A Biol. Sci. Med. Sci., October 1, 2005; 60(10): 1252 - 1264.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
L. Yang, S. Xie, Md. S. Jamaluddin, S. Altuwaijri, J. Ni, E. Kim, Y.-T. Chen, Y.-C. Hu, L. Wang, K.-H. Chuang, et al.
Induction of Androgen Receptor Expression by Phosphatidylinositol 3-Kinase/Akt Downstream Substrate, FOXO3a, and Their Roles in Apoptosis of LNCaP Prostate Cancer Cells
J. Biol. Chem., September 30, 2005; 280(39): 33558 - 33565.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
N. Gao, Y. Dai, M. Rahmani, P. Dent, and S. Grant
Contribution of Disruption of the Nuclear Factor-{kappa}B Pathway to Induction of Apoptosis in Human Leukemia Cells by Histone Deacetylase Inhibitors and Flavopiridol
Mol. Pharmacol., October 1, 2004; 66(4): 956 - 963.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2003 by the American Association for Cancer Research.